Albireo Gets Back-to-Back Approvals for Rare Liver Disease Drug
On July 20th, Albireo announced that the FDA approved Bylvay to treat pruritus in all subtypes of progressive familial intrahepatic cholestasis (PFIC). This is a huge milestone for the company, …
Read More